319 related articles for article (PubMed ID: 27671543)
41. Longitudinal assessment of bone density and structure in childhood survivors of acute lymphoblastic leukemia without cranial radiation.
Mostoufi-Moab S; Brodsky J; Isaacoff EJ; Tsampalieros A; Ginsberg JP; Zemel B; Shults J; Leonard MB
J Clin Endocrinol Metab; 2012 Oct; 97(10):3584-92. PubMed ID: 22865901
[TBL] [Abstract][Full Text] [Related]
42. Estimation of lumbar spine bone mineral density by dual-energy X-ray absorptiometry: standard anteroposterior scans vs sub-regional analyses of whole-body scans.
Boyanov M
Br J Radiol; 2008 Aug; 81(968):637-42. PubMed ID: 18628333
[TBL] [Abstract][Full Text] [Related]
43. Bone mineral density in long-term survivors of childhood cancer.
Hesseling PB; Hough SF; Nel ED; van Riet FA; Beneke T; Wessels G
Int J Cancer Suppl; 1998; 11():44-7. PubMed ID: 9876477
[TBL] [Abstract][Full Text] [Related]
44. Bone loss after childhood acute lymphoblastic leukaemia: an observational study with and without GH therapy.
Follin C; Link K; Wiebe T; Moëll C; Björk J; Erfurth EM
Eur J Endocrinol; 2011 May; 164(5):695-703. PubMed ID: 21378089
[TBL] [Abstract][Full Text] [Related]
45. Is the treatment for childhood solid tumors associated with lower bone mass than that for leukemia and Hodgkin disease?
Muszynska-Roslan K; Konstantynowicz J; Panasiuk A; Krawczuk-Rybak M
Pediatr Hematol Oncol; 2009 Jan; 26(1):36-47. PubMed ID: 19206007
[TBL] [Abstract][Full Text] [Related]
46. Body composition in long-term survivors of acute lymphoblastic leukemia diagnosed in childhood and adolescence: A focus on sarcopenic obesity.
Marriott CJC; Beaumont LF; Farncombe TH; Cranston AN; Athale UH; Yakemchuk VN; Webber CE; Barr RD
Cancer; 2018 Mar; 124(6):1225-1231. PubMed ID: 29231963
[TBL] [Abstract][Full Text] [Related]
47. Bone mineral density in pediatric survivors of Hodgkin and non-Hodgkin lymphomas.
Muszynska-Roslan K; Latoch E; Konstantynowicz J; Panasiuk A; Stewart A; Krawczuk-Rybak M
Adv Med Sci; 2014 Sep; 59(2):200-5. PubMed ID: 25323758
[TBL] [Abstract][Full Text] [Related]
48. Effects of growth hormone therapy on bone mass, metabolic balance, and well-being in young adult survivors of childhood acute lymphoblastic leukemia.
van den Heijkant S; Hoorweg-Nijman G; Huisman J; Drent M; van der Pal H; Kaspers GJ; Delemarre-van de Waal H
J Pediatr Hematol Oncol; 2011 Aug; 33(6):e231-8. PubMed ID: 21792029
[TBL] [Abstract][Full Text] [Related]
49. Germline variation in the MTHFR and MTRR genes determines the nadir of bone density in pediatric acute lymphoblastic leukemia: a prospective study.
te Winkel ML; de Muinck Keizer-Schrama SM; de Jonge R; van Beek RD; van der Sluis IM; Hop WC; Pieters R; van den Heuvel-Eibrink MM
Bone; 2011 Mar; 48(3):571-7. PubMed ID: 20955826
[TBL] [Abstract][Full Text] [Related]
50. Changes in bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Kaste SC; Rai SN; Fleming K; McCammon EA; Tylavsky FA; Danish RK; Rose SR; Sitter CD; Pui CH; Hudson MM
Pediatr Blood Cancer; 2006 Jan; 46(1):77-87. PubMed ID: 16106430
[TBL] [Abstract][Full Text] [Related]
51. Changes in bone mineral density during therapy in childhood acute lymphoblastic leukemia.
Kaushik A; Bansal D; Khandelwal N; Trehan A; Marwaha RK
Indian Pediatr; 2009 Mar; 46(3):245-8. PubMed ID: 19213989
[TBL] [Abstract][Full Text] [Related]
52. Risk and determinants of low and very low bone mineral density and fractures in a national cohort of Dutch adult childhood cancer survivors (DCCSS-LATER): a cross-sectional study.
van Atteveld JE; de Winter DTC; Pluimakers VG; Fiocco M; Nievelstein RAJ; Hobbelink MGG; de Vries ACH; Loonen JJ; van Dulmen-den Broeder E; van der Pal HJ; Pluijm SMF; Kremer LCM; Ronckers CM; van der Heiden-van der Loo M; Versluijs AB; Louwerens M; Bresters D; van Santen HM; Olsson DS; Hoefer I; van den Berg SAA; den Hartogh J; Tissing WJE; Neggers SJCMM; van den Heuvel-Eibrink MM;
Lancet Diabetes Endocrinol; 2023 Jan; 11(1):21-32. PubMed ID: 36513116
[TBL] [Abstract][Full Text] [Related]
53. Bone mineralization defects after treatment of acute lymphoblastic leukemia ın children.
Guren Dolu M; Canbolat Ayhan A; Erguven M; Timur C; Yoruk A; Ozdemir S
Minerva Pediatr; 2015 Oct; 67(5):419-25. PubMed ID: 26377781
[TBL] [Abstract][Full Text] [Related]
54. Bone mineral density at diagnosis determines fracture rate in children with acute lymphoblastic leukemia treated according to the DCOG-ALL9 protocol.
te Winkel ML; Pieters R; Hop WC; Roos JC; Bökkerink JP; Leeuw JA; Bruin MC; Kollen WJ; Veerman AJ; de Groot-Kruseman HA; van der Sluis IM; van den Heuvel-Eibrink MM
Bone; 2014 Feb; 59():223-8. PubMed ID: 24287213
[TBL] [Abstract][Full Text] [Related]
55. Bone turnover in long-term survivors of childhood acute lymphoblastic leukemia.
Watsky MA; Carbone LD; An Q; Cheng C; Lovorn EA; Hudson MM; Pui CH; Kaste SC
Pediatr Blood Cancer; 2014 Aug; 61(8):1451-6. PubMed ID: 24648266
[TBL] [Abstract][Full Text] [Related]
56. Bone mineral density in children with acute lymphoblastic leukaemia.
Boot AM; van den Heuvel-Eibrink MM; Hählen K; Krenning EP; de Muinck Keizer-Schrama SM
Eur J Cancer; 1999 Nov; 35(12):1693-7. PubMed ID: 10674015
[TBL] [Abstract][Full Text] [Related]
57. Risk factors and surveillance for reduced bone mineral density in pediatric cancer survivors.
Siegel DA; Claridy M; Mertens A; George E; Vangile K; Simoneaux SF; Meacham LR; Wasilewski-Masker K
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28233475
[TBL] [Abstract][Full Text] [Related]
58. Bone mineral density, growth, and thyroid function in long-term survivors of pediatric Hodgkin's lymphoma treated with chemotherapy only.
van Beek RD; van den Heuvel-Eibrink MM; Hakvoort-Cammel FG; van den Bos C; van der Pal HJ; Krenning EP; de Rijke YB; Pieters R; de Muinck Keizer-Schrama SM
J Clin Endocrinol Metab; 2009 Jun; 94(6):1904-9. PubMed ID: 19293271
[TBL] [Abstract][Full Text] [Related]
59. [Bone mineral density and markers of bone turnover in patients treated for malignant disease in childhood].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M; Łuczyński W; Kaczmarski M; Wołczynski S; Piotrowska-Jastrzebska J
Med Wieku Rozwoj; 2004; 8(4 Pt 2):1041-54. PubMed ID: 15951599
[TBL] [Abstract][Full Text] [Related]
60. The Progression of Bone Mineral Density Abnormalities After Chemotherapy for Childhood Acute Lymphoblastic Leukemia.
Vitanza NA; Hogan LE; Zhang G; Parker RI
J Pediatr Hematol Oncol; 2015 Jul; 37(5):356-61. PubMed ID: 25222061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
